📚 Hematology — L5: Hemostatic & Bleeding Disorders

📚 Lecture Overview

This lecture explores the complex physiological and pathological mechanisms of hemostatic and bleeding disorders. It covers the four major components of normal hemostasis—vascular, platelet, coagulation, and fibrinolytic systems—alongside the diagnosis, clinical manifestations, and management of various bleeding and thrombotic conditions. Understanding these concepts is essential for differentiating between vascular, platelet, and coagulation defects in clinical practice.

🎯 Key Concepts & Definitions

• Hemostasis: The physiological process by which the body spontaneously stops bleeding and maintains blood in a fluid state within the vascular compartment.
• Primary Hemostasis: The initial response to vascular injury involving vasoconstriction and the formation of a primary platelet plug.
• Secondary Hemostasis: The activation of the coagulation cascade, leading to the conversion of fibrinogen into a stabilized fibrin mesh.
• Idiopathic Thrombocytopenic Purpura (ITP): An acquired immune-mediated disorder characterized by isolated thrombocytopenia due to autoantibody-mediated platelet destruction and impaired production.
• Disseminated Intravascular Coagulation (DIC): A systemic condition characterized by widespread activation of coagulation, leading to microvascular thrombi consumption of clotting factors, and severe bleeding.
• Von Willebrand Disease (VWD): An inherited bleeding disorder caused by a deficiency or qualitative defect of von Willebrand factor, impairing platelet adhesion.
• Hemophilia A: An X-linked recessive bleeding disorder caused by a deficiency or dysfunction of coagulation Factor VIII.

📖 Main Content

1. Physiology of Normal Hemostasis

The body maintains hemostasis through four major interconnected systems:
- Vascular System: Induces vasoconstriction and releases thromboplastin and prostacyclin.
- Platelets: Adhere to subendothelial connective tissue via receptors (GpIb, GpIIb, GpIIIa, GpIa) and release storage granule contents (ADP, calcium, serotonin, fibrinogen, and vWF).
- Fibrin Clot: Formed via the intrinsic and extrinsic coagulation pathways to stabilize the platelet plug.
- Fibrinolytic System: Limits and regulates clot extension through the action of plasmin.

2. Vascular Bleeding Disorders

Vascular disorders typically present with mild bleeding, easy bruising, petechiae, purpura, or ecchymosis.
- Inherited Disorders:
- Hereditary Hemorrhagic Telangiectasia: Autosomal dominant condition causing multiple dilations of small vessels that bleed easily.
- Ehlers-Danlos Syndrome: Autosomal dominant collagen defect leading to vascular fragility.
- Acquired Disorders:
- Vitamin C Deficiency: Causes scurvy; defective intercellular cement due to failed hydroxylation of collagen and elastin.
- Henoch-Schönlein Purpura: Immune complex disease common in children, presenting with purpuric lesions on buttocks and extensor surfaces.
- Senile Purpura: Caused by atrophy of subcutaneous supportive tissues in the elderly.

3. Platelet Disorders

Platelets are produced by bone marrow megakaryocytes under the regulation of thrombopoietin (normal count: 150–450 $× 10^9$/L; lifespan: 7–10 days).
- Quantitative Disorders:
- Failure of production: Aplastic anemia, megaloblastic anemia, and rare syndromes like Wiskott-Aldrich and Bernard-Soulier.
- Increased destruction: ITP (acute in children, chronic in adults), drug-induced immune thrombocytopenia, and microangiopathic conditions (HUS, TTP, DIC).
- ITP Diagnosis & Treatment: Diagnosis is by exclusion showing isolated thrombocytopenia on CBC. First-line treatment involves corticosteroids or IVIG; second-line options include TPO receptor agonists (Romiplostim, Eltrombopag), Rituximab, or splenectomy.
- Qualitative Disorders:
- Glanzmann’s Thrombasthenia: Deficiency of GpIIb/IIIa causing failure of primary aggregation.
- Bernard-Soulier Syndrome: Deficiency of GpIb leading to defective binding to vWF.
- Acquired agents: Aspirin (inhibits cyclooxygenase and thromboxane A2), Clopidogrel, and uremia.

4. Coagulation Disorders & Screening Tests

The coagulation cascade involves proenzyme factors circulating in plasma that sequentially activate to generate thrombin, which converts fibrinogen to fibrin.
- Natural Inhibitors: Tissue factor pathway inhibitor (TFPI), Antithrombin III (potentiated by heparin), and the Protein C / Protein S system.
- Screening Tests:
- Prothrombin Time (PT): Evaluates extrinsic pathway (Factors VII, X, V, II, I). Prolonged in liver disease and warfarin therapy.
- Activated Partial Thromboplastin Time (APTT): Evaluates intrinsic pathway (Factors XII, XI, IX, VIII, X, V, II, I). Prolonged in hemophilia.
- Thrombin Time (TT): Evaluates fibrinogen abnormalities or heparin therapy.

5. Congenital & Acquired Coagulation Defects

• Hemophilia A: X-linked recessive deficiency of Factor VIII. Presents with hemarthrosis, deep muscle bleeds, and post-traumatic hemorrhage. Treated with Factor VIII concentrates or Desmopressin (mild cases).
• Hemophilia B (Christmas Disease): Deficiency of Factor IX.
• Vitamin K Deficiency: Impairs synthesis of vitamin K-dependent factors (II, VII, IX, X). Treated with Vitamin K and fresh frozen plasma (FFP).
• Liver Disease: Causes multi-factor synthesis failure, thrombocytopenia, and dysfibrinogenemia.
• Disseminated Intravascular Coagulation (DIC): Triggered by sepsis, trauma, or obstetric complications. Characterized by consumption coagulopathy, thrombocytopenia, elevated FDPs / D-dimers, microangiopathic hemolytic anemia, and prolonged PT/APTT/TT. Treated by addressing the underlying cause and replacing blood products.

📊 Visual Learning

💡 Important Points to Remember

• Normal Platelet Count: 150 to 450 $× 10^9$/L with a lifespan of 7–10 days.
• Bleeding Time Normal Range: 3 to 8 minutes.
• Glanzmann vs. Bernard-Soulier: Glanzmann involves GpIIb/IIIa deficiency (fails all aggregations); Bernard-Soulier involves GpIb deficiency (large platelets, fails ristocetin aggregation).
• Hemophilia A Genetics: X-linked recessive, affects males, transmitted by carrier females, caused by Factor VIII deficiency.
• Vitamin K-Dependent Factors: Factors II, VII, IX, and X (plus anticoagulant proteins C and S).
• PT evaluates: Extrinsic pathway (Factor VII) and liver function / warfarin.
• APTT evaluates: Intrinsic pathway (Factors VIII, IX, XI, XII) and heparin therapy.
• ITP Diagnosis: Diagnosis of exclusion featuring isolated thrombocytopenia; normal spleen/liver size rules out hypersplenism.
• DIC Laboratory Hallmarks: Decreased fibrinogen, prolonged PT/APTT/TT, presence of schistocytes, and elevated D-dimers / FDPs.
• Antithrombin III: The most potent natural inhibitor, whose action is markedly potentiated by heparin.

⚠️ Common Exam Questions

• Examiner Trick in MCQs: Confusing which platelet receptor binds to von Willebrand factor. Remember: GpIb binds to vWF (deficient in Bernard-Soulier), while GpIIb/IIIa is responsible for platelet-to-platelet aggregation (deficient in Glanzmann's).
• Coagulation Test Traps: Students often mix up PT and APTT pathways. Use the mnemonic OT (Outer/Extrinsic = PT) and IN (Inner/Intrinsic = APTT).
• ITP vs. Hypersplenism: Exam questions often present a patient with thrombocytopenia and hepatosplenomegaly, asking for the diagnosis. Remember that true ITP presents with isolated thrombocytopenia; hepatosplenomegaly suggests an alternative diagnosis like chronic liver disease or hypersplenism.

📝 Quick Review Checklist

I can explain the four major systems involved in normal hemostasis
I understand the difference between primary and secondary hemostasis defects
I can define ITP and its standard first and second-line treatments
I know the receptor deficiencies in Glanzmann's and Bernard-Soulier syndromes
I understand the coagulation cascade pathways and their screening tests (PT, APTT)
I can list the vitamin K-dependent clotting factors
I know the inheritance pattern and clinical features of Hemophilia A
I understand the pathophysiology, lab findings, and management of DIC